Showing results (1-10 of 182) with videos related to
Sort By:
Pageof 19
Clinical Breast Cancer|June 13, 2006
Adjuvant taxanes in the treatment of breast cancer: no longer at the tip of the icebergChau Dang, Clifford HudisThe Breast Journal|December 23, 2014
The development of dose-dense adjuvant chemotherapyClifford Hudis, Chau DangBreast (Edinburgh, Scotland)|August 29, 2007
Current status of the taxanes as adjuvant therapy for breast cancerClifford Hudis, Heather McArthur, Chau DangBreast (Edinburgh, Scotland)|September 27, 2005
The best use of adjuvant chemotherapy: new drugs and new use of "old" drugsClifford HudisClinical Breast Cancer|January 21, 2003
Adjuvant use of taxanes for patients with breast cancer: we see the tip of the icebergClifford HudisCurrent Oncology Reports|December 22, 2004
Adjuvant chemotherapy for primary breast cancerMonica Fornier, Clifford HudisCritical Reviews in Oncology/Hematology|October 31, 2003
Follow-up care of breast cancer survivorsArti Hurria, Clifford HudisCancer|May 13, 2004
Cardiac profiles of liposomal anthracyclines: greater cardiac safety versus conventional doxorubicin?Maria Theodoulou, Clifford HudisCancer Control : Journal of the Moffitt Cancer Center|January 7, 2003
Aromatase inhibitors in breast cancer: an updateDiana E Lake, Clifford HudisJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrheaChau Dang, Nancy Lin, Beverly Moy, et al.Pageof 19